• 1
    Heitman, J., Movva, N. R. and Hall, M. N., Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science 1991. 253: 905909.
  • 2
    Sarbassov, D. D., Ali, S. M., Sengupta, S., Sheen, J. H., Hsu, P. P., Bagley, A. F., Markhard, A. L. et al., Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol. Cell 2006. 22: 159168.
  • 3
    Sengupta, S., Peterson, T. R. and Sabatini, D. M., Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress. Mol. Cell 2010. 40: 310322.
  • 4
    Kamada, Y., Funakoshi, T., Shintani, T., Nagano, K., Ohsumi, M. and Ohsumi, Y., Tor-mediated induction of autophagy via an Apg1 protein kinase complex. J. Cell. Biol. 2000. 150: 15071513.
  • 5
    Menon, S. and Manning, B. D., Common corruption of the mTOR signaling network in human tumors. Oncogene 2008. 27: S43S51.
  • 6
    Powell, J. D. and Delgoffe, G. M., The mammalian target of rapamycin: linking T cell differentiation, function, and metabolism. Immunity 2010. 33: 301311.
  • 7
    Morice, W. G., Brunn, G. J., Wiederrecht, G., Siekierka, J. J. and Abraham, R. T., Rapamycin-induced inhibition of p34cdc2 kinase activation is associated with G1/S-phase growth arrest in T lymphocytes. J. Biol. Chem. 1993. 268: 37343738.
  • 8
    Haxhinasto, S., Mathis, D. and Benoist, C., The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells. J. Exp. Med. 2008. 205: 565574.
  • 9
    Araki, K., Turner, A. P., Shaffer, V. O., Gangappa, S., Keller, S. A., Bachmann, M. F., Larsen, C. P. and Ahmed, R., mTOR regulates memory CD8 T-cell differentiation. Nature 2009. 460: 108112.
  • 10
    Brown, V. I., Fang, J., Alcorn, K., Barr, R., Kim, J. M., Wasserman, R. and Grupp, S. A., Rapamycin is active against B-precursor leukemia in vitro and in vivo, an effect that is modulated by IL-7-mediated signaling. Proc. Natl. Acad. Sci. USA 2003. 100: 1511315118.
  • 11
    Lazorchak, A. S., Liu, D., Facchinetti, V., Di Lorenzo, A., Sessa, W. C., Schatz, D. G. and Su, B., Sin1-mTORC2 suppresses rag and il7r gene expression through Akt2 in B cells. Mol. Cell 2010. 39: 433443.
  • 12
    Dan, H. C., Sun, M., Yang, L., Feldman, R. I., Sui, X. M., Ou, C. C., Nellist, M. et al., Phosphatidylinositol 3-kinase/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin. J. Biol. Chem. 2002. 277: 3536435370.
  • 13
    Castro, A. F., Rebhun, J. F., Clark, G. J. and Quilliam, L. A., Rheb binds tuberous sclerosis complex 2 (TSC2) and promotes S6 kinase activation in a rapamycin- and farnesylation-dependent manner. J. Biol. Chem. 2003. 278: 3249332496.
  • 14
    Wang, L., Harris, T. E., Roth, R. A. and Lawrence, J. C., Jr., PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding. J. Biol. Chem. 2007. 282: 2003620044.
  • 15
    Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J. et al., Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999. 96: 857868.
  • 16
    Anzelon, A. N., Wu, H. and Rickert, R. C., Pten inactivation alters peripheral B lymphocyte fate and reconstitutes CD19 function. Nat. Immunol. 2003. 4: 287294.
  • 17
    Chen, J., Limon, J. J., Blanc, C., Peng, S. L. and Fruman, D. A., Foxo1 regulates marginal zone B-cell development. Eur. J. Immunol. 2010. 40: 18901896.
  • 18
    Srinivasan, L., Sasaki, Y., Calado, D. P., Zhang, B., Paik, J. H., DePinho, R. A., Kutok, J. L. et al., PI3 kinase signals BCR-dependent mature B cell survival. Cell 2009. 139: 573586.
  • 19
    Kwiatkowski, D. J., Zhang, H., Bandura, J. L., Heiberger, K. M., Glogauer, M., el-Hashemite, N. and Onda, H., A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells. Hum. Mol. Genet. 2002. 11: 525534.
  • 20
    Hao, Z. and Rajewsky, K., Homeostasis of peripheral B cells in the absence of B cell influx from the bone marrow. J. Exp. Med. 2001. 194: 11511164.
  • 21
    Weichhart, T., Costantino, G., Poglitsch, M., Rosner, M., Zeyda, M., Stuhlmeier, K. M., Kolbe, T., et al., The TSC-mTOR signaling pathway regulates the innate inflammatory response. Immunity 2008. 29: 565577.
  • 22
    Donahue, A. C. and Fruman, D. A., Distinct signaling mechanisms activate the target of rapamycin in response to different B-cell stimuli. Eur. J. Immunol. 2007. 37: 29232936.
  • 23
    Ozcan, U., Ozcan, L., Yilmaz, E., Duvel, K., Sahin, M., Manning, B. D. and Hotamisligil, G. S., Loss of the tuberous sclerosis complex tumor suppressors triggers the unfolded protein response to regulate insulin signaling and apoptosis. Mol. Cell 2008. 29: 541551.